Brief: BioArctic Reports Q4 Sales Of Leqembi At SEK 20.7 Billion
Corrects currency in headline Feb 6 (Reuters) - BioArctic AB BIOAb.ST: SALES OF LEQEMBI TOTALED 20.7 BILLION YEN IN THE FOURTH QUARTER 2025 RECEIVES SEK 127 MILLION ROYALTY FROM LEQEMBI SALES Source text: ID:nWkr74lwNb Further company coverage: [BIOAb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million